Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06378892
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2024-04-10
Brief Title:
A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer NSCLC With Exclusively Extracranial Disease Progression on Lorlatinib
Sponsor:
Centro di Riferimento Oncologico - Aviano
Organization:
Centro di Riferimento Oncologico - Aviano
Organization Data
Organization:
Centro di Riferimento Oncologico - Aviano
Class:
OTHER
Study ID:
CRO-2023-78
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centro di Riferimento Oncologico - Aviano
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None